The global intubation tubes market is expected to reach USD 4.3 billion by 2030, expanding at a CAGR of 6.7% from 2023 to 2030. The increasing number of surgical procedures due to the rising prevalence of chronic diseases and technological advancements in medical supplies are the major growth-propelling factors for the market.
Intubation tubes are an essential rescue procedure in the emergency setting. The most common approaches of intubation tubes are direct and video laryngoscopy. Intubation tubes indications include poor ventilation, altered mental status, and poor oxygenation. The role of intubation tubes in the emergency setting is to obtain first-pass success and secure the patient’s airway. Many patients can experience swallowing and sore throat immediately after intubation, but recovery is usually quick, depending on the patient’s overall recovery.
The COVID-19 pandemic has had a significant impact on the market. The majority of critical patients during the COVID-19 pandemic require respiratory support. In a healthcare setting intubation tubes are required to secure a patient’s airways. For instance, Paris Fire Brigade Advanced Life Support teams used intubation tubes for 18 patients out of 300 suffering from COVID-19.
Chronic respiratory diseases are one the most common non-communicable diseases globally due to environmental, occupational, and behavioral inhalational exposures. More than 3.23 million deaths occurs in 2019 due to chronic obstructive pulmonary disease which makes it the 3rd leading cause of death in the world. More than 90% of COPD deaths occur mostly under 70 years of age in low- and middle-income economies. Early diagnosis and treatment can help to slow the progression of symptoms and reduce flare-ups.
Intubation tubes are an essential rescue procedure in the emergency setting. The most common approaches of intubation tubes are direct and video laryngoscopy. Intubation tubes indications include poor ventilation, altered mental status, and poor oxygenation. The role of intubation tubes in the emergency setting is to obtain first-pass success and secure the patient’s airway. Many patients can experience swallowing and sore throat immediately after intubation, but recovery is usually quick, depending on the patient’s overall recovery.
The COVID-19 pandemic has had a significant impact on the market. The majority of critical patients during the COVID-19 pandemic require respiratory support. In a healthcare setting intubation tubes are required to secure a patient’s airways. For instance, Paris Fire Brigade Advanced Life Support teams used intubation tubes for 18 patients out of 300 suffering from COVID-19.
Chronic respiratory diseases are one the most common non-communicable diseases globally due to environmental, occupational, and behavioral inhalational exposures. More than 3.23 million deaths occurs in 2019 due to chronic obstructive pulmonary disease which makes it the 3rd leading cause of death in the world. More than 90% of COPD deaths occur mostly under 70 years of age in low- and middle-income economies. Early diagnosis and treatment can help to slow the progression of symptoms and reduce flare-ups.
Intubation Tubes Market Report Highlights
- The gastric intubation segment is expected to show the fastest growth over the forecast period as it is a common procedure in clinical anesthesiology to achieve gastric decompression
- Trachea intubation held the largest share as of 2022 owing to the increasing number of surgical procedures in healthcare settings
- The ambulatory surgical center’s segment is expected to show lucrative growth over the forecast period as it is a cost-efficient healthcare setting that cost 60% less than hospital surgeries
- The hospitals held the largest share as of 2022 owing to the high number of patient admission in the hospitals
Table of Contents
Chapter 1 Methodology and Scope1.1 Market Segmentation & Scope
1.1.1 Product Type
1.1.2 End - Use
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Intubation Tubes Market: Variables, Trends, & Scope
3.1 Market Segmentation And Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Porter’s Five Forces Analysis
3.5 Pestel Analysis
3.6 Covid - 19 Impact Analysis
Chapter 4 Intubation Tubes Market: Product Type Segment Analysis
4.1 Intubation Tubes Market: Market Share Analysis, 2022 & 2030
4.1.1 Trachea Intubation
4.1.1.1 Trachea Intubation Market, 2018 - 2030 (USD Million)
4.1.2 Gastric Intubation
4.1.2.1 Gastric Intubation Market, 2018 - 2030 (USD Million)
Chapter 5 Intubation Tubes Market: End - Use Segment Analysis
5.1 Intubation Tubes Market: Market Share Analysis, 2022 & 2030
5.1.1 Hospitals
5.1.1.1 Hospitals Market, 2018 - 2030 (USD Million)
5.1.2 Ambulatory Surgical Centers
5.1.2.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
5.1.3 Others
5.1.3.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 Intubation Tubes Market: Regional Analysis
6.1 Intubation Tubes: Regional Market Share Analysis, 2022 & 2030
6.2 North America
6.2.1 North America market, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. market, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Market, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe market, 2018 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. market, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Market, 2018 - 2030 (USD Million)
6.3.4 France
6.3.4.1 France Market, 2018 - 2030 (USD Million)
6.3.5 Italy
6.3.5.1 Italy Market, 2018 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain Market, 2018 - 2030 (USD Million)
6.3.7 Denmark
6.3.7.1 Denmark Market, 2018 - 2030 (USD Million)
6.3.8 Sweden
6.3.8.1 Sweden Market, 2018 - 2030 (USD Million)
6.3.9 Norway
6.3.9.1 Norway Market, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Market, 2018 - 2030 (USD Million)
6.4.2 China
6.4.2.1 China Market, 2018 - 2030 (USD Million)
6.4.3 India
6.4.3.1 India Market, 2018 - 2030 (USD Million)
6.4.4 Australia
6.4.4.1 Australia Market, 2018 - 2030 (USD Million)
6.4.5 South Korea
6.4.5.1 South Korea Market, 2018 - 2030 (USD Million)
6.4.6 Japan
6.4.6.1 Japan Market, 2018 - 2030 (USD Million)
6.4.7 Thailand
6.4.7.1 Thailand Market, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Market, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Market, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Market, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina market, 2018 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA market, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Market, 2018 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia market, 2018 - 2030 (USD Million)
6.6.4 UAE
6.6.4.1 UAE market, 2018 - 2030 (USD Million)
6.6.5 Kuwait
6.6.5.1 Kuwait market, 2018 - 2030 (USD Million)
Chapter 7 Company Profiles
7.1 Recent Development by Key Market Players
7.2 Company/Competition Categorization (Key Innovators, Market Leaders)
7.2.1 PARTICIPANT Categorization
7.3 Intubation Tubes - market share analysis
7.4 Company Profiles
7.4.1 TELEFLEX CORPORATION
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiative
7.4.2 MEDTRONIC
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiative
7.4.3 MEDLINE INDUSTRIES
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiative
7.4.4 VENNER MEDICAL
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiative
7.4.5 SONOMA PHARMACEUTICAL
7.4.5.1 Company overview
7.4.5.2 Financial Performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 HOSPITEKNIK HEALTHCARE
7.4.6.1 Company Overview
7.4.6.2 Product Benchmarking
7.4.6.3 Financial performance
7.4.6.4 Strategic initiatives
7.4.7 ARMSTRONG MEDICAL
7.4.7.1 Company Overview
7.4.7.2 Product Benchmarking
7.4.7.3 Financial performance
7.4.7.4 Strategic initiatives
7.4.8 AIRWAY INNOVATIONS
7.4.8.1 Company Overview
7.4.8.2 Product Benchmarking
7.4.8.3 Financial performance
7.4.8.4 Strategic initiatives
7.4.9 SMITHS GROUP
7.4.9.1 Company overview
7.4.9.2 Product Benchmarking
7.4.9.3 Financial performance
7.4.9.4 Strategic initiatives
7.4.10 CONVATEC, INC.
7.4.10.1 Company Overview
7.4.10.2 Product Benchmarking
7.4.10.3 Financial performance
7.4.10.4 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Intubation tubes market snapshot (2022)
Fig. 9 Intubation tubes market segmentation
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Porter’s five forces analysis
Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 14 Intubation tubes market product type outlook: Segment dashboard
Fig. 15 Intubation tubes market: Product type movement analysis
Fig. 16 Trachea intubation market, 2018 - 2030 (USD Million)
Fig. 17 Gastric intubation market, 2018 - 2030 (USD Million)
Fig. 18 Intubation tubes market end-use outlook: Segment dashboard
Fig. 19 Intubation tubes market: End-use movement analysis
Fig. 20 Hospitals market, 2018 - 2030 (USD Million)
Fig. 21 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
Fig. 22 Others market, 2018 - 2030 (USD Million)
Fig. 23 Regional market: Key takeaways
Fig. 24 Regional outlook, 2018 & 2030
Fig. 25 North America market, 2018 - 2030 (USD Million)
Fig. 26 U.S. market, 2018 - 2030 (USD Million)
Fig. 27 Canada market, 2018 - 2030 (USD Million)
Fig. 28 Europe market, 2018 - 2030 (USD Million)
Fig. 29 U.K. market, 2018 - 2030 (USD Million)
Fig. 30 Germany market, 2018 - 2030 (USD Million)
Fig. 31 France market, 2018 - 2030 (USD Million)
Fig. 32 Italy market, 2018 - 2030 (USD Million)
Fig. 33 Spain market, 2018 - 2030 (USD Million)
Fig. 34 Denmark market, 2018 - 2030 (USD Million)
Fig. 35 Sweden market, 2018 - 2030 (USD Million)
Fig. 36 Norway market, 2018 - 2030 (USD Million)
Fig. 37 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 38 China market, 2018 - 2030 (USD Million)
Fig. 39 India market, 2018 - 2030 (USD Million)
Fig. 40 Australia market, 2018 - 2030 (USD Million)
Fig. 41 South Korea market, 2018 - 2030 (USD Million)
Fig. 42 Japan market, 2018 - 2030 (USD Million)
Fig. 43 Thailand market, 2018 - 2030 (USD Million)
Fig. 44 Latin America market, 2018 - 2030 (USD Million)
Fig. 45 Brazil market, 2018 - 2030 (USD Million)
Fig. 46 Mexico market, 2018 - 2030 (USD Million)
Fig. 47 Argentina market, 2018 - 2030 (USD Million)
Fig. 48 MEA market, 2018 - 2030 (USD Million)
Fig. 49 South Africa market, 2018 - 2030 (USD Million)
Fig. 50 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 51 UAE market, 2018 - 2030 (USD Million)
Fig. 52 Kuwait market, 2018 - 2030 (USD Million)
Companies Mentioned
- TELEFLEX CORPORATION
- MEDTRONIC
- MEDLINE INDUSTRIES
- VENNER MEDICAL
- SONOMA PHARMACEUTICAL
- HOSPITEKNIK HEALTHCARE
- ARMSTRONG MEDICAL
- AIRWAY INNOVATIONS
- SMITHS GROUP
- CONVATEC, INC.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | January 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.7 Billion |
| Forecasted Market Value ( USD | $ 4.3 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
